Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-29
DOI
10.1186/s12935-020-01283-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1
- (2020) Kejin Wang et al. OncoTargets and Therapy
- Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
- (2020) Zedong Li et al. Cancer Medicine
- A dynamic reversible RNA N6 -methyladenosine modification: current status and perspectives
- (2019) Zhen Bi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
- (2019) Yi Niu et al. Molecular Cancer
- Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma – a retrospective study using TCGA database
- (2019) Jingcheng Zhou et al. Aging-US
- MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation
- (2019) Sara Sdelci et al. NATURE GENETICS
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
- (2019) Ting Li et al. Molecular Cancer
- Molecular characterization and clinical relevance of m6A regulators across 33 cancer types
- (2019) Yongsheng Li et al. Molecular Cancer
- WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
- (2019) Yunhao Chen et al. Molecular Cancer
- Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway
- (2019) Xiaodong Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Relationship between IGF2BP2 and IGFBP3 polymorphisms and susceptibility to non-small-cell lung cancer: a case–control study in Eastern Chinese Han population
- (2018) Shuchen Chen et al. Cancer Management and Research
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- Thyroid cancer
- (2016) Maria E Cabanillas et al. LANCET
- Correlation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han women
- (2015) Guihong Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- 5′ UTR m6A Promotes Cap-Independent Translation
- (2015) Kate D. Meyer et al. CELL
- Gene expression regulation mediated through reversible m6A RNA methylation
- (2014) Ye Fu et al. NATURE REVIEWS GENETICS
- Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
- (2014) Minjing Zou et al. THYROID
- New developments in the diagnosis and treatment of thyroid cancer
- (2013) David F. Schneider et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
- (2012) Kate D. Meyer et al. CELL
- Serum TSH and Risk of Papillary Thyroid Cancer in Nodular Thyroid Disease
- (2012) Emilio Fiore et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research
- (2012) Anna Asplund et al. PROTEOMICS
- A flexible R package for nonnegative matrix factorization
- (2010) Renaud Gaujoux et al. BMC BIOINFORMATICS
- Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy
- (2010) A. M. Moyer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival
- (2009) Nobuyuki Wada et al. BMC CANCER
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started